NYSE : IPI

Intrepid Potash, Inc.

$34.2 USD

-$0.01 (-0.03%)

Volume
111.42K
Average Volume
233.52K
Market Capitalization
$459.41M
P/E Ratio
32.04
Dividend Yield
0.00%
Price Target
$26.00
Year High
$50.34
Year Low
$22.55
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$5.26
Source Headline
Intrepid Announces Date for Second Quarter 2026 Earnings Release

DENVER--(BUSINESS WIRE)--Intrepid Potash, Inc. (NYSE: IPI) plans to release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market closes. Intrepid will host a conference call on Wednesday, August 5, 2026, at 12:00 p.m. Eastern Time to discuss the results, outlook, and other operating and financial matters and answer investor questions.Management invites you to listen to the conference call by using the toll-free dial-in number 1 (833) 461-5787 or International di.

businesswire.com - 2026-07-09 16:30:00

Is Intrepid Potash (IPI) Stock Outpacing Its Basic Materials Peers This Year?

Here is how Intrepid Potash (IPI) and Neo Performance Materials Inc. (NOPMF) have performed compared to their sector so far this year.

zacks.com - 2026-07-02 10:40:39

Intrepid Potash Inc (IPI) Shares Fall 4.7% -- What GF Score of 70 Tells Investors

On June 16, 2026, Intrepid Potash Inc (IPI) shares fell 4.7%, bringing the current price to $34.19. The stock has experienced a significant decline recently, wi

gurufocus.com - 2026-06-16 20:46:00

Are Basic Materials Stocks Lagging Intrepid Potash (IPI) This Year?

Here is how Intrepid Potash (IPI) and Nucor (NUE) have performed compared to their sector so far this year.

zacks.com - 2026-06-16 10:40:56

Intrepid Potash Announces Appointment of Jason Tremblay as Chief Financial Officer

DENVER--(BUSINESS WIRE)--Intrepid Potash, Inc. (“Intrepid”, “the Company”, “we”, “us”, or “our”) (NYSE:IPI) today announced the appointment of Jason Tremblay as Chief Financial Officer, effective June 15, 2026. Mr. Tremblay brings nearly three decades of leadership experience across finance, strategy, operations, and business transformation within the mining, agriculture, and crop nutrition industries. Mr. Tremblay joins Intrepid from The Mosaic Company (NYSE: MOS), where he most recently serve.

businesswire.com - 2026-06-15 16:30:00

Results from Incyte's Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progr

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min

gurufocus.com - 2026-06-13 06:00:00

Intrepid Potash (IPI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for Intrepid Potash (IPI), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

zacks.com - 2026-06-05 10:57:20

Intrepid Potash Increases Share Repurchase Authorization to $50M

IPI raises its share repurchase authorization to $50M, backed by stronger operations and a healthier balance sheet.

zacks.com - 2026-06-04 11:06:04

Intrepid Potash Announces Expansion of Common Stock Repurchase Plan

DENVER--(BUSINESS WIRE)--Intrepid Potash, Inc. (“Intrepid”, “the Company”, “we”, “us”, or “our”) (NYSE:IPI) today announced that its Board of Directors (“Board”) approved an increase in the amount authorized for repurchasing shares of the Company's common stock under the Company's existing share repurchase program. The Board expanded the authorized amount to $50 million, an increase from the $35 million the program originally authorized in February 2022, which has approximately $13 million rema.

businesswire.com - 2026-06-03 16:25:00

Incyte's Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patie

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min

gurufocus.com - 2026-05-30 09:00:00

American Critical Minerals Receives Final BLM Potash Prospecting Permits for 2026 Drill Program at Green River Project

VANCOUVER, BC / ACCESS Newswire / May 26, 2026 / American Critical Minerals Corp. ("American Critical Minerals" or the "Company") (CSE:KCLI)(OTCQB:APCOF)(Frankfurt:2P30) is pleased to announce that it has received all final Potassium Prospecting Permits from the Bureau of Land Management ("BLM"), effective June 1, 2026. As well, the BLM and the State of Utah have accepted the combined reclamation bond of US$549,000.

accessnewswire.com - 2026-05-26 05:00:00

Volatility to Turn Higher as Inflation Resurfaces: Stocks to Watch

Inflation is the biggest risk in this environment amid the Strait of Hormuz blockade, which continues to pressure global energy prices.

zacks.com - 2026-05-14 12:05:36

Intrepid Potash Q1 Earnings Call Highlights

Intrepid Potash NYSE: IPI reported a stronger start to 2026, with management citing higher fertilizer pricing, resilient demand and operational improvements across its potash and Trio businesses during the company's first-quarter earnings call.

marketbeat.com - 2026-05-10 21:07:20

Intrepid Potash, Inc. (IPI) Q1 2026 Earnings Call Transcript

Intrepid Potash, Inc. (IPI) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-07 15:11:29

Intrepid Potash (IPI) Q1 Earnings Surpass Estimates

Intrepid Potash (IPI) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.39 per share a year ago.

zacks.com - 2026-05-06 22:45:42

Intrepid Announces First Quarter 2026 Results

DENVER--(BUSINESS WIRE)--Intrepid Potash, Inc. ("Intrepid", "the Company", "we", "us", or "our") (NYSE:IPI) today reported its results for the first quarter of 2026. First Quarter Highlights & Management Commentary Supportive prices, resilient demand for potash and Trio®, and continued improvement in Trio® margins led to another quarter of strong financial results, highlighted by: Sales from continuing operations of $98.7 million; Net income from continuing operations of $6.9 million, or $0.

businesswire.com - 2026-05-06 16:30:00

American Critical Minerals Engages RESPEC to Execute Its 2026 Drill Program at Green River Project

VANCOUVER, BC / ACCESS Newswire / April 23, 2026 / American Critical Minerals Corp. ("American Critical Minerals" or the "Company") (CSE:KCLI)(OTCQB:APCOF)(Frankfurt:2P3) is pleased to announce that it has engaged RESPEC Company LLC ("RESPEC") to manage and execute its drilling program at its Green River Potash, Lithium, and Bromine Project located in the Paradox basin, east central Utah. Highlights RESPEC is well versed in the Paradox Basin and has a solid track record on both potash and lithium brine projects.

accessnewswire.com - 2026-04-23 05:00:00

Get IPI Insider Trade Alerts

IPI Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$26.00

1 analysts

Last Year

$25.00

2 analysts

All Time

$28.25

4 analysts

IPI Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-05-14 UBS Maintain Sell Sell
2026-03-05 UBS Maintain Sell Sell
2026-01-12 UBS Maintain Sell Sell
2025-08-07 UBS Maintain Sell Sell
2025-07-23 UBS Maintain Sell Sell
2025-04-16 UBS Maintain Sell Sell
2025-03-04 UBS Maintain Sell Sell
2025-01-28 UBS Maintain Sell Sell
2024-11-05 UBS Maintain Sell Sell
2024-05-10 BMO Capital Maintain Market Perform Market Perform
2023-11-10 BMO Capital Maintain Market Perform Market Perform
2023-05-05 BMO Capital Maintain Market Perform Market Perform
2023-01-11 UBS Maintain Sell Sell
2022-11-04 BMO Capital Maintain Market Perform Market Perform
2022-07-13 UBS Maintain Sell Sell
2022-01-04 UBS Maintain Sell Sell
2020-11-25 UBS Downgrade Neutral Sell
2020-11-25 Morgan Stanley Maintain Equal Weight Equal Weight
2020-11-25 BMO Capital Maintain Market Perform Perform
2020-11-25 BMO Capital Downgrade Market Perform Underperform
2020-11-25 UBS Maintain Sell Sell
2020-11-25 Wunderlich Maintain Buy Buy
2020-11-25 BGC Financial Upgrade Hold Buy
2020-11-25 BGC Financial Downgrade Buy Hold
2020-11-25 PiperJaffray Downgrade Overweight Neutral
2020-11-25 Cowen & Co. Upgrade Underperform Perform
2020-11-25 Barclays Downgrade Equal Weight Underweight
2020-11-25 Stephens & Co. Upgrade Equal Weight Overweight
2020-11-25 Susquehanna Upgrade Negative Neutral
2020-11-25 Dahlman Rose Downgrade Hold Sell
2020-11-25 Susquehanna Downgrade Neutral Sell
2020-11-25 Goldman Sachs Maintain Neutral Neutral
2020-11-25 Scotiabank Upgrade Sector Underperform Perform
2020-11-25 Barclays Maintain Equal Weight Equal Weight
2020-11-25 Cowen & Co. Downgrade Market Perform Underperform
2020-11-25 BMO Capital Upgrade Underperform Perform
2020-11-25 Susquehanna Maintain Neutral Neutral
2020-11-25 Vertical Research Downgrade Buy Hold
2020-11-25 CLSA Downgrade Buy Underperform
2020-11-25 KeyBanc Downgrade Buy Hold
2020-11-25 CLSA Maintain Outperform Buy
2020-11-25 Scotiabank Downgrade Outperform Perform
2020-11-04 Roth Capital Maintain Buy Buy
2020-11-04 BMO Capital Maintain Market Perform Market Perform
2020-07-09 UBS Maintain Sell Sell
2018-10-31 BMO Capital Maintain Market Perform Market Perform
2018-08-06 BMO Capital Maintain Market Perform Market Perform
2018-05-09 Stephens & Co. Upgrade Equal Weight Overweight
2018-03-05 Cowen & Co. Upgrade Underperform Market Perform
2017-12-05 Stephens & Co. Maintain Equal Weight Equal Weight
2017-10-31 BMO Capital Maintain Market Perform Market Perform
2017-08-07 UBS Downgrade Neutral Sell
2017-08-03 BMO Capital Maintain Market Perform Market Perform
2016-05-10 CLSA Upgrade Underperform Outperform
2016-04-14 Cowen & Co. Downgrade Market Perform Underperform
2016-01-26 Susquehanna Maintain Neutral Neutral
2016-01-19 Societe Generale Maintain Sector Perform Perform
2015-11-24 Vertical Research Downgrade Buy Hold
2015-11-02 Susquehanna Maintain Neutral Neutral
2015-10-28 CLSA Downgrade Buy Underperform
2015-10-14 Cowen & Co. Upgrade Underperform Market Perform
2015-07-29 Susquehanna Maintain Neutral Neutral
2015-04-29 CLSA Maintain Outperform Buy
2015-04-07 PiperJaffray Downgrade Overweight Neutral
2015-04-07 Piper Sandler Downgrade Overweight Neutral
2014-10-31 BMO Capital Upgrade Underperform Market Perform
2014-10-07 Susquehanna Upgrade Negative Neutral
2014-08-13 BGC FInancial Downgrade Hold Sell
2014-08-13 BGC Financial Downgrade Hold Sell
2014-07-31 Scotiabank Upgrade Sector Underperform Sector Perform
2014-06-17 PiperJaffray Maintain Overweight Overweight
2014-02-18 Susquehanna Upgrade Negative Neutral
2013-12-17 Macquarie Maintain Neutral Neutral
2013-12-04 RBC Capital Maintain Sector Perform Perform
2013-11-13 Susquehanna Downgrade Neutral Sell
2013-11-13 Susquehanna Downgrade Neutral Negative
2013-11-01 BGC Financial Downgrade Buy Hold
2013-11-01 BGC FInancial Downgrade Buy Hold
2013-09-26 BMO Capital Downgrade Market Perform Underperform
2013-08-09 BGC FInancial Upgrade Hold Buy
2013-08-09 BGC Financial Upgrade Hold Buy
2013-07-31 Barclays Downgrade Equal Weight Underweight
2013-07-31 Wunderlich Maintain Buy Buy
2013-07-31 Wunderlich Securities Maintain Buy Buy
2013-05-02 Scotiabank Downgrade Outperform Sector Perform
2013-05-02 Scotiabank Downgrade Outperform Perform
2013-04-18 BMO Capital Maintain Market Perform Market Perform
2013-02-19 Dahlman Rose Downgrade Hold Sell
2013-02-15 BMO Capital Maintain Market Perform Market Perform
2013-02-15 Goldman Sachs Maintain Neutral Neutral
2013-02-15 Morgan Stanley Maintain Equal Weight Equal Weight
2013-01-17 Credit Suisse Maintain Neutral Neutral
2013-01-07 Keybanc Downgrade Buy Hold
2013-01-07 KeyBanc Downgrade Buy Hold
2012-10-18 Barclays Maintain Equal Weight Equal Weight
2012-09-18 Topeka Maintain Buy Buy
2012-09-11 Wunderlich Maintain Buy Buy
2012-08-15 Barclays Maintain Equal Weight Equal Weight
2012-05-04 Morgan Stanley Maintain Equal Weight Equal Weight
2012-04-24 KeyBanc Maintain Buy Buy
2012-02-21 Scotiabank Maintain Sector Outperform Outperform